Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Depreciation & Amortization (CF) (2020 - 2023)

Rapid Therapeutic Science Laboratories' Depreciation & Amortization (CF) history spans 4 years, with the latest figure at $5993.0 for Q2 2023.

  • For Q2 2023, Depreciation & Amortization (CF) changed 0.0% year-over-year to $5993.0; the TTM value through Jun 2023 reached $23972.0, up 4.06%, while the annual FY2022 figure was $23972.0, 8.47% up from the prior year.
  • Depreciation & Amortization (CF) for Q2 2023 was $5993.0 at Rapid Therapeutic Science Laboratories, roughly flat from $5993.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $5993.0 in Q1 2022 and bottomed at $2418.0 in Q3 2020.
  • The 4-year median for Depreciation & Amortization (CF) is $5993.0 (2022), against an average of $5497.8.
  • The largest annual shift saw Depreciation & Amortization (CF) soared 128.49% in 2021 before it changed 0.0% in 2023.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at $2418.0 in 2020, then skyrocketed by 128.49% to $5525.0 in 2021, then rose by 8.47% to $5993.0 in 2022, then changed by 0.0% to $5993.0 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Depreciation & Amortization (CF) are $5993.0 (Q2 2023), $5993.0 (Q1 2023), and $5993.0 (Q4 2022).